OVERVIEW
Rett syndrome (RTT) is a severe and progressive neurodevelopmental disorder that is characterized by a variety of neurologic and behavioral features. Although RTT is a rare disorder, it is the second most common cause of severe intellectual disability among females and early diagnosis is critical for patients so they may receive appropriate interventions. In this live, interactive symposium, expert faculty will discuss the latest evidence and data regarding the role of genetics in the diagnosis and management of patients with RTT. Real-world patient cases will help learners contextualize genetic testing results and develop treatment plans to apply in their practices.
GOAL STATEMENT
The goal of this activity is for learners to be better able to recognize and manage patients with Rett syndrome.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the:[list][item]Genetic mutations with Rett syndrome[item]Clinical data for therapies studied for the management of Rett syndrome[/list]Have greater competence related to:[list][item]Interpretation of genetic testing for Rett syndrome[item]Developing a comprehensive treatment plan for Rett syndrome[/list]
ACCREDITATION STATEMENT
[MEDSCAPE][JALOGO] In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of [bold][italic]1.5 AMA PRA Category 1 Credits[/bold][/italic]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Delta Toronto Hotel
Soco Ballroom
75 Lower Simcoe St 6
Toronto, Ontario, M5J 3A
Canada